1021144-32-0

Usage

Uses

Used in Pharmaceutical Industry:
4-(2-methyl-1H-benzo[d]imidazol-1-yl)benzoic acid is used as a key intermediate in the synthesis of pharmaceuticals for its potential therapeutic properties. It is particularly being studied for its role in the treatment of cancer and inflammatory diseases due to its bioactive nature.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(2-methyl-1H-benzo[d]imidazol-1-yl)benzoic acid is used as a building block for the creation of novel organic molecules. Its unique structure allows for the development of new compounds with specific properties, which can be tailored for various applications.
Used in Material Science:
4-(2-methyl-1H-benzo[d]imidazol-1-yl)benzoic acid is also utilized in material science for the development of new materials. Its chemical properties make it a candidate for use in the creation of advanced materials with specific characteristics for use in various industries.
Used in Research and Development:
In the research and development sector, 4-(2-methyl-1H-benzo[d]imidazol-1-yl)benzoic acid is employed as a subject of study for understanding its potential applications and for discovering new uses in medicine and other fields. Its exploration can lead to advancements in drug discovery and material innovation.

Upstream product

• 884069-09-4 methyl 4-(2-methylbenzimidazol-1-yl)benzoate 
• 615-15-6 2-Methyl-1H-benzimidazole 
• 403-33-8 methyl 4-flurobenzoate 

Downstream Products

• 1087328-07-1 (S)-tert-butyl 3-(4-(2-methyl-1H-benzo[d]imidazol-1-yl)benzamido)-pyrrolidine-1-carboxylate 
• 1087333-82-1 N-methyl-4-(2-methyl-1H-benzimidazol-1-yl)-N-[(3R)-1-methylpyrrolidin-3-yl]benzamide 
• 1087327-91-0 N-methyl-4-(2-methyl-1H-benzimidazol-1-yl)-N-[(3R)-pyrrolidin-3-yl]benzamide 
• 1087327-90-9 3-{methyl-[4-(2-methylbenzimidazol-1-yl)benzoyl]amino}-(R)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1087328-08-2 3-{methyl-[4-(2-methyl-benzoimidazol-1-yl)-benzoyl]-amino}-(S)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1087337-26-5 4-(2-methyl-1H-benzimidazol-1-yl)-N-[(3R)-pyrrolidin-3-yl]benzamide 
• 1087386-64-8 N-ethyl-4-(2-methyl-1H-benzimidazol-1-yl)-N-[(3R)-pyrrolidin-3-yl]benzamide 
• 1087328-09-3 N-methyl-4-(2-methyl-1H-benzimidazol-1-yl)-N-[(3S)-pyrrolidin-3-yl]benzamide 
• 1087330-95-7 3-{ethyl-[4-(2-methyl-benzoimidazol-1-yl)-benzoyl]-amino}-(R)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1087386-67-1 N-[(3R)-1-cyclopentylpyrrolidin-3-yl]-N-ethyl-4-(2-methyl-1H-benzimidazol-1-yl)benzamide 
• 1087386-62-6 N-[(3R)-1-cyclopentylpyrrolidin-3-yl]-4-(2-methyl-1H-benzimidazol-1-yl)benzamide 
• 1087386-66-0 N-[(3R)-1-cyclobutylpyrrolidin-3-yl]-N-ethyl-4-(2-methyl-1H-benzimidazol-1-yl)benzamide 
• 1087386-65-9 N-ethyl-N-[(3R)-1-isopropylpyrrolidin-3-yl]-4-(2-methyl-1H-benzimidazol-1-yl)benzamide 
• 1087386-61-5 N-[(3R)-1-isopropylpyrrolidin-3-yl]-4-(2-methyl-1H-benzimidazol-1-yl)benzamide 

Relevant academic research and scientific papers

Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists

On the basis of the previously reported benzimidazole 1,3′- bipyrrolidine benzamides (1), a series of related pyrrolidin-3-yl-N- methylbenzamides were synthesized and evaluated as H3 receptor antagonists. In particular, compound 32 exhibits pot

AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS

The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor